BRIEF-ELSALYS BIOTECH ACQUIRES FROM JAZZ PHARMA WORLDWIDE RIGHTS OF LEUKOTAC
Oct 12, 2017 - Reuters

Oct 12 (Reuters) - Elsalys Biotech: * ELSALYS BIOTECH ACQUIRES FROM JAZZ PHARMACEUTICALS THE WORLDWIDE RIGHTS OF LEUKOTAC * ‍ELSALYS BIOTECH SAYS HAS INITIATED DISCUSSION WITH EUROPEAN HEALTH AUTHORITIES AND WILL ENGAGE IN REGULATORY INTERACTIONS WITH FDA IN 2018​ Source text for Eikon: Further company coverage:

Existing user? Log in

Forgot your password?

Existing user? Log in